Skip to main content

GeneNews Gains ISO Certification for Product Development Quality System

NEW YORK (GenomeWeb News) — GeneNews said today it has received certification from the International Organization for Standardization for its Quality Management System, which covers both design and development of in vitro diagnostic test kits that are used in managing colorectal cancer.

Meeting the ISO requirements will help GeneNews gain international regulatory approval for its blood-based molecular diagnostics products, said company CEO Wayne Marshall.

Marshall said that the certification, which was earned after an audit in December 2007 by TUV SUD America, will be an important step in the company’s commercialization strategy.

The company’s first product in development is the ColonSentry, a blood-based biomarker test designed to identify current risk of colorectal cancer. GeneNews said it is using its Sentinel Principle technology in other areas, including cardiovascular disease, arthritis, and neurological disorders.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.